Skip to the page

Data / Form D filings / Affect Therapeutics, Inc.

Affect Therapeutics, Inc.: Form D filings

Affect Therapeutics, Inc., a health care company in Mclean, VA, filed 2 Form D notices with the SEC between 2021 and 2023. The latest, on July 12, 2023, reports $18.1 million sold of a $18.1 million offering to 9 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1640 Boro Place, 4th Floor, Mclean, VA, 22102
Phone
(929) 552-2849
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1883067

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 12, 2023New notice$18,073,362$18,073,3629Dec 16, 2022sec.gov
Sep 23, 2021New notice$6,504,278$6,504,27810Jun 23, 2021sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jeff RinehartDirector
Kevin RyanDirector
Jeff DeFlavioDirector
Stuart PetersonDirector
Kristin MuhlnerExecutive Officer, Director

Other health care companies in Virginia that filed recently

Every Form D from the week of Jul 10, 2023 · All recent filings in Virginia · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Affect Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.